Overactivation of the kynurenine pathway, particularly IDO, is associated with an unfavorable prognosis in various cancer types, including gastrointestinal cancers, gynecological cancers, hematological malignancies, breast cancer, lung cancer, glioma, melanoma, prostate cancer, and pancreatic cancer. The gene discussed is IDO1; the disease is Familial prostate cancer.